Literature DB >> 22267200

Discovery of common variants associated with low TSH levels and thyroid cancer risk.

Julius Gudmundsson1, Patrick Sulem, Daniel F Gudbjartsson, Jon G Jonasson, Gisli Masson, Huiling He, Aslaug Jonasdottir, Asgeir Sigurdsson, Simon N Stacey, Hrefna Johannsdottir, Hafdis Th Helgadottir, Wei Li, Rebecca Nagy, Matthew D Ringel, Richard T Kloos, Marieke C H de Visser, Theo S Plantinga, Martin den Heijer, Esperanza Aguillo, Angeles Panadero, Enrique Prats, Almudena Garcia-Castaño, Ana De Juan, Fernando Rivera, G Bragi Walters, Hjordis Bjarnason, Laufey Tryggvadottir, Gudmundur I Eyjolfsson, Unnur S Bjornsdottir, Hilma Holm, Isleifur Olafsson, Kristleifur Kristjansson, Hoskuldur Kristvinsson, Olafur T Magnusson, Gudmar Thorleifsson, Jeffrey R Gulcher, Augustine Kong, Lambertus A L M Kiemeney, Thorvaldur Jonsson, Hannes Hjartarson, Jose I Mayordomo, Romana T Netea-Maier, Albert de la Chapelle, Jon Hrafnkelsson, Unnur Thorsteinsdottir, Thorunn Rafnar, Kari Stefansson.   

Abstract

To search for sequence variants conferring risk of nonmedullary thyroid cancer, we focused our analysis on 22 SNPs with a P < 5 × 10(-8) in a genome-wide association study on levels of thyroid stimulating hormone (TSH) in 27,758 Icelanders. Of those, rs965513 has previously been shown to associate with thyroid cancer. The remaining 21 SNPs were genotyped in 561 Icelandic individuals with thyroid cancer (cases) and up to 40,013 controls. Variants suggestively associated with thyroid cancer (P < 0.05) were genotyped in an additional 595 non-Icelandic cases and 2,604 controls. After combining the results, three variants were shown to associate with thyroid cancer: rs966423 on 2q35 (OR = 1.34; P(combined) = 1.3 × 10(-9)), rs2439302 on 8p12 (OR = 1.36; P(combined) = 2.0 × 10(-9)) and rs116909374 on 14q13.3 (OR = 2.09; P(combined) = 4.6 × 10(-11)), a region previously reported to contain an uncorrelated variant conferring risk of thyroid cancer. A strong association (P = 9.1 × 10(-91)) was observed between rs2439302 on 8p12 and expression of NRG1, which encodes the signaling protein neuregulin 1, in blood.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267200      PMCID: PMC3655412          DOI: 10.1038/ng.1046

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  30 in total

1.  Identification of low-frequency variants associated with gout and serum uric acid levels.

Authors:  Patrick Sulem; Daniel F Gudbjartsson; G Bragi Walters; Hafdis T Helgadottir; Agnar Helgason; Sigurjon A Gudjonsson; Carlo Zanon; Soren Besenbacher; Gyda Bjornsdottir; Olafur T Magnusson; Gisli Magnusson; Eirikur Hjartarson; Jona Saemundsdottir; Arnaldur Gylfason; Adalbjorg Jonasdottir; Hilma Holm; Ari Karason; Thorunn Rafnar; Hreinn Stefansson; Ole A Andreassen; Jesper H Pedersen; Allan I Pack; Marieke C H de Visser; Lambertus A Kiemeney; Arni J Geirsson; Gudmundur I Eyjolfsson; Isleifur Olafsson; Augustine Kong; Gisli Masson; Helgi Jonsson; Unnur Thorsteinsdottir; Ingileif Jonsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2011-10-09       Impact factor: 38.330

2.  Allelic variation in gene expression in thyroid tissue.

Authors:  Huiling He; Katie Olesnanik; Rebecca Nagy; Sandya Liyanarachchi; Manju L Prasad; Constantine A Stratakis; Richard T Kloos; Albert de la Chapelle
Journal:  Thyroid       Date:  2005-07       Impact factor: 6.568

3.  Protection of privacy by third-party encryption in genetic research in Iceland.

Authors:  J R Gulcher; K Kristjánsson; H Gudbjartsson; K Stefánsson
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

4.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database.

Authors:  Kamila Czene; Paul Lichtenstein; Kari Hemminki
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

5.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

6.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.

Authors:  D E Goldgar; D F Easton; L A Cannon-Albright; M H Skolnick
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

Review 7.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia.

Authors:  Tetsuo Kondo; Shereen Ezzat; Sylvia L Asa
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

8.  An integrated regulatory network controlling survival and migration in thyroid organogenesis.

Authors:  Rosanna Parlato; Annamaria Rosica; Alina Rodriguez-Mallon; Andrea Affuso; Maria Pia Postiglione; Claudio Arra; Ahmed Mansouri; Shioko Kimura; Roberto Di Lauro; Mario De Felice
Journal:  Dev Biol       Date:  2004-12-15       Impact factor: 3.582

9.  A novel endonuclease IV post-PCR genotyping system.

Authors:  Igor V Kutyavin; Dave Milesi; Yevgeniy Belousov; Mikhail Podyminogin; Alexei Vorobiev; Vladimir Gorn; Eugeny A Lukhtanov; Nicolaas M J Vermeulen; Walt Mahoney
Journal:  Nucleic Acids Res       Date:  2006-09-29       Impact factor: 16.971

10.  Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family.

Authors:  Laufey T Amundadottir; Sverrir Thorvaldsson; Daniel F Gudbjartsson; Patrick Sulem; Kristleifur Kristjansson; Sigurdur Arnason; Jeffrey R Gulcher; Johannes Bjornsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  PLoS Med       Date:  2004-12-28       Impact factor: 11.069

View more
  101 in total

1.  The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.

Authors:  Ruta Sahasrabudhe; Ana Estrada; Paul Lott; Lynn Martin; Guadalupe Polanco Echeverry; Alejandro Velez; Gila Neta; Meiko Takahasi; Vladimir Saenko; Norisato Mitsutake; Emma Jaeguer; Carlos Simon Duque; Alejandro Rios; Mabel Bohorquez; Rodrigo Prieto; Angel Criollo; Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal Carmona
Journal:  Endocr Relat Cancer       Date:  2015-08-19       Impact factor: 5.678

2.  PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Authors:  Jaroslaw Jendrzejewski; Andrew Thomas; Sandya Liyanarachchi; Andrew Eiterman; Jerneja Tomsic; Huiling He; Hanna S Radomska; Wei Li; Rebecca Nagy; Krzysztof Sworczak; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2015-08-14       Impact factor: 5.958

Review 3.  Genome-Wide Association Studies of Cancer in Diverse Populations.

Authors:  Sungshim L Park; Iona Cheng; Christopher A Haiman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-21       Impact factor: 4.254

4.  Increased risk of papillary thyroid cancer related to hormonal factors in women.

Authors:  Ping Wang; Long Lv; Feng Qi; Feng Qiu
Journal:  Tumour Biol       Date:  2015-02-11

5.  Unraveling the genetic predisposition to differentiated thyroid carcinoma.

Authors:  Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2013-10       Impact factor: 5.958

6.  A genome-wide association study yields five novel thyroid cancer risk loci.

Authors:  Julius Gudmundsson; Gudmar Thorleifsson; Jon K Sigurdsson; Lilja Stefansdottir; Jon G Jonasson; Sigurjon A Gudjonsson; Daniel F Gudbjartsson; Gisli Masson; Hrefna Johannsdottir; Gisli H Halldorsson; Simon N Stacey; Hannes Helgason; Patrick Sulem; Leigha Senter; Huiling He; Sandya Liyanarachchi; Matthew D Ringel; Esperanza Aguillo; Angeles Panadero; Enrique Prats; Almudena Garcia-Castaño; Ana De Juan; Fernando Rivera; Li Xu; Lambertus A Kiemeney; Gudmundur I Eyjolfsson; Olof Sigurdardottir; Isleifur Olafsson; Hoskuldur Kristvinsson; Romana T Netea-Maier; Thorvaldur Jonsson; Jose I Mayordomo; Theo S Plantinga; Hannes Hjartarson; Jon Hrafnkelsson; Erich M Sturgis; Unnur Thorsteinsdottir; Thorunn Rafnar; Albert de la Chapelle; Kari Stefansson
Journal:  Nat Commun       Date:  2017-02-14       Impact factor: 14.919

7.  MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.

Authors:  Yanqiang Wang; Huiling He; Wei Li; John Phay; Rulong Shen; Lianbo Yu; Baris Hancioglu; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

8.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

9.  Fine mapping of 14q13 reveals novel variants associated with different histological subtypes of papillary thyroid carcinoma.

Authors:  Jarosław Jendrzejewski; Sandya Liyanarachchi; Andrew Eiterman; Andrew Thomas; Huiling He; Rebecca Nagy; Leigha Senter; Krzysztof Sworczak; Albert de la Chapelle
Journal:  Int J Cancer       Date:  2018-12-03       Impact factor: 7.396

Review 10.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.